Johns Hopkins ABX Guide →Brand Names

Amphotericin B liposomal

Kathryn Dzintars, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Amphotericin B liposomal is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Aspergillosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
  • Candidiasis (in patients refractory to or intolerant of amphotericin B deoxycholate)
  • Cryptococcosis (in patients refractory to or intolerant of amphotericin B deoxycholate)
  • Empiric therapy for presumed fungal infection in patients with febrile neutropenia
  • Visceral leishmaniasis

NON-FDA APPROVED USES

  • Zygomycetes and other invasive molds
  • Coccidioidomycosis
  • Histoplasmosis

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: February 26, 2017

Citation

TY - ELEC T1 - Amphotericin B liposomal ID - 540022 A1 - Dzintars,Kathryn,Pharm.D., BCPS AU - Pham,Paul,Pharm.D. Y1 - 2017/02/26/ PB - Johns Hopkins ABX Guide UR - https://www.unboundmedicine.com/medline/view/Johns_Hopkins_ABX_Guide/540022/all/Amphotericin_B_liposomal ER -